Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2 V617F "indeterminate" results by MutaScreen can be easily resolved using MutaQuant kits.

Genetic testing and molecular biomarkers - 1 Feb 2012

Hoteit Rouba M, Shammaa Dina M R, Mahfouz Rami A R

Abstract excerpt

AIM: Janus kinase 2 (JAK2) V617F mutation testing has revolutionized the classification of myeloproliferative disorders, for which several tests have been introduced for qualitative and quantitative diagnostics including the MutaScreen and MutaQuant kits by IPSOGEN. One interesting technical observation are those values detected by MutaScreen kits, which have typically "indeterminate" meaning at a provided...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mutational Analysis
Share to Janus Kinase 2
Share to Myeloproliferative Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymerase Chain Reaction

Share to Reagent Kits, Diagnostic

Share to Reference Standards

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 21933004
DOI: 10.1089/gtmb.2011.0100

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

JAK2 V617F "indeterminate" results by MutaScreen can be easily resolved using MutaQuant kits.PMID 21933004Read ↗

[Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening].Semantic proximity Read ↗

Is Low Positive JAK2 V617F Mutation Test Result Clinically Significant?: Multi-Institutional Study.Semantic proximity Read ↗

Clinical Performance of <i>JAK2</i> V617F Mutation Detection Assays in a Molecular Diagnostics LaboratorySemantic proximity Read ↗

Detection of the JAK2 V617F Mutation in Urinary Cell-free DNA in Patients with Myeloproliferative Neoplasms.Semantic proximity Read ↗

Validation of standards for quantitative assessment of JAK2 c.1849G>T (p.V617F) allele burden analysis in clinical samples.Semantic proximity Read ↗

Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories.Semantic proximity Read ↗

Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection.Semantic proximity Read ↗

Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.